Lawyer profile
Lacey Henry
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- FDA regulatory, FDA regulatory matters, healthcare and life sciences
- Office
- New York
- Active in the record
- 2020 to 2021
Deal experience
Deals
5 announced deals in the record Latham & Watkins Advises the Underwriters in Lyell Immunopharma’s US$425 Million IPO 17 Jun 2021
Latham & Watkins Advises Science 37 in US$1.05 billion de-SPAC transaction with LifeSci Acquisition II Corp. 7 May 2021
Latham & Watkins Advises Boston Scientific in US$1.07 Billion Acquisition of Lumenis LTD. Surgical Business 3 Mar 2021
Latham & Watkins advises the underwriters in Harpoon Therapeutics Public Offering 7 Jan 2021
Latham & Watkins Advises Ascendis Pharma A/S in Public Offering of ADSs 8 Jul 2020
Deal alerts PRO
Get an email when Lacey Henry is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile